Danilo Fliser

35.7k total citations · 5 hit papers
301 papers, 18.6k citations indexed

About

Danilo Fliser is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Danilo Fliser has authored 301 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Nephrology, 67 papers in Cardiology and Cardiovascular Medicine and 53 papers in Molecular Biology. Recurrent topics in Danilo Fliser's work include Dialysis and Renal Disease Management (58 papers), Chronic Kidney Disease and Diabetes (40 papers) and Erythropoietin and Anemia Treatment (35 papers). Danilo Fliser is often cited by papers focused on Dialysis and Renal Disease Management (58 papers), Chronic Kidney Disease and Diabetes (40 papers) and Erythropoietin and Anemia Treatment (35 papers). Danilo Fliser collaborates with scholars based in Germany, United States and France. Danilo Fliser's co-authors include Jan T. Kielstein, Eberhard Ritz, Hermann Haller, Gunnar H. Heine, Jürgen Floege, Michael Böhm, Ferdinand H. Bahlmann, Joachim Jankowski, Hermann Haller and Stefanie M. Bode‐Böger and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Danilo Fliser

294 papers receiving 18.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular Disease in Chronic Kidney Disease

2021 1.1k citations Joachim Jankowski, Jürgen Floege et al. Circulation profile →
Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease

2007 568 citations Danilo Fliser, Barbara Kollerits et al. Journal of the American Society of Nephrology profile →
Chronic kidney disease and the global public health agenda: an international consensus

2024 387 citations Alberto Ortíz, Danilo Fliser et al. Nature Reviews Nephrology profile →
WNT–β-catenin signalling — a versatile player in kidney injury and repair

2020 303 citations Stefan Schunk, Jürgen Floege et al. Nature Reviews Nephrology profile →
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

2022 135 citations Thimoteus Speer, Stefanie Dimmeler et al. Nature Reviews Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danilo Fliser Germany	75	6.6k	4.3k	4.0k	2.7k	2.3k	301	18.6k
Enyu Imai Japan	61	7.4k 1.1×	3.6k 0.8×	4.8k 1.2×	3.0k 1.1×	1.5k 0.7×	324	18.7k
David A. Roth United States	47	6.6k 1.0×	4.1k 1.0×	2.3k 0.6×	3.0k 1.1×	1.3k 0.6×	212	20.6k
Ziad A. Massy France	69	11.5k 1.7×	3.1k 0.7×	3.6k 0.9×	3.9k 1.4×	2.5k 1.1×	440	21.9k
Agnes B. Fogo United States	86	10.1k 1.5×	3.8k 0.9×	7.1k 1.8×	2.7k 1.0×	1.9k 0.8×	501	23.7k
Yasuhiko Tomino Japan	57	11.0k 1.7×	2.8k 0.7×	3.7k 0.9×	2.4k 0.9×	1.7k 0.7×	626	19.7k
Hermann Haller Germany	80	4.4k 0.7×	4.8k 1.1×	7.0k 1.7×	4.1k 1.5×	1.9k 0.8×	454	23.0k
Marta Ruiz‐Ortega Spain	70	4.7k 0.7×	3.8k 0.9×	6.9k 1.7×	2.0k 0.7×	1.6k 0.7×	265	18.2k
Masaomi Nangaku Japan	82	8.4k 1.3×	2.4k 0.6×	6.9k 1.7×	2.5k 0.9×	2.0k 0.9×	712	24.1k
Kosaku Nitta Japan	46	7.6k 1.1×	3.0k 0.7×	2.1k 0.5×	2.3k 0.8×	1.1k 0.5×	598	14.8k
Franz Schaefer Germany	60	8.0k 1.2×	3.3k 0.8×	3.0k 0.7×	2.6k 1.0×	1.2k 0.5×	417	17.8k

Countries citing papers authored by Danilo Fliser

Since Specialization

Citations

This map shows the geographic impact of Danilo Fliser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Fliser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Fliser more than expected).

Fields of papers citing papers by Danilo Fliser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danilo Fliser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Fliser. The network helps show where Danilo Fliser may publish in the future.

Co-authorship network of co-authors of Danilo Fliser

This figure shows the co-authorship network connecting the top 25 collaborators of Danilo Fliser. A scholar is included among the top collaborators of Danilo Fliser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danilo Fliser. Danilo Fliser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abu‐Omar, Amina, Danilo Fliser, Tina Schmidt, et al.. (2025). Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients. American Journal of Transplantation. 26(3). 499–511.

Fliser, Danilo, et al.. (2024). Roxadustat Efficacy and Safety in Patients Receiving Peritoneal Dialysis: Pooled Analysis of Four Phase 3 Studies. Journal of Clinical Medicine. 13(22). 6729–6729. 1 indexed citations

Arjune, Sita, Martin R. Späth, Stefan Schunk, et al.. (2023). DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease. Clinical Kidney Journal. 17(1). sfad262–sfad262. 6 indexed citations

Fliser, Danilo, et al.. (2023). Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries. International Journal of Nephrology and Renovascular Disease. Volume 16. 115–129.

Speer, Thimoteus, Stefanie Dimmeler, Stefan Schunk, Danilo Fliser, & Paul M. Ridker. (2022). Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nature Reviews Nephrology. 18(12). 762–778. 135 indexed citations breakdown →

Radhakrishnan, Kamalakannan, Yong‐Hoon Kim, Yoon Seok Jung, et al.. (2021). Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injury. Proceedings of the National Academy of Sciences. 118(16). 21 indexed citations

Emrich, Insa E., Gunnar H. Heine, P. Christian Schulze, et al.. (2021). Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study. Pharmacology Research & Perspectives. 9(4). e00801–e00801. 3 indexed citations

Jankowski, Joachim, Jürgen Floege, Danilo Fliser, Michael Böhm, & Nikolaus Marx. (2021). Cardiovascular Disease in Chronic Kidney Disease. Circulation. 143(11). 1157–1172. 1066 indexed citations breakdown →

Küllmar, Mira, Khaschayar Saadat-Gilani, Raphael Weiß, et al.. (2020). Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients. American Journal of Respiratory and Critical Care Medicine. 203(9). 1119–1126. 35 indexed citations

10.

Schlieper, Georg, Vedat Schwenger, Andrew Remppis, et al.. (2017). Antikoagulation bei Patienten mit chronischer Niereninsuffizienz : Empfehlungen der Arbeitsgemeinschaft "Herz Niere" der Deutschen Gesellschaft für Kardiologie Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Nephrologie.. Der Internist. 58(5). 512–521. 2 indexed citations

11.

Rogacev, Kyrill S., Bodo Cremers, Adam M. Zawada, et al.. (2012). CD14++CD16+ Monocytes Independently Predict Cardiovascular Events. Journal of the American College of Cardiology. 60(16). 1512–1520. 417 indexed citations

12.

Zawada, Adam M., Kyrill S. Rogacev, Stephan H. Schirmer, et al.. (2012). Monocyte heterogeneity in human cardiovascular disease. Immunobiology. 217(12). 1273–1284. 106 indexed citations

13.

Ulrich, Christof, et al.. (2009). Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome. Nephrology Dialysis Transplantation. 24(11). 3480–3486. 24 indexed citations

14.

Spanaus, Katharina, Florian Kronenberg, Eberhard Ritz, et al.. (2007). B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study. Clinical Chemistry. 53(7). 1264–1272. 106 indexed citations

15.

Fliser, Danilo, Ferdinand H. Bahlmann, & Hermann Haller. (2006). EPO: renoprotection beyond anemia correction. Pediatric Nephrology. 21(12). 1785–1789. 35 indexed citations

16.

Rifai, Kinan, Carsten Hafer, Jens Rosenau, et al.. (2006). Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®). Scandinavian Journal of Gastroenterology. 41(10). 1212–1217. 28 indexed citations

17.

Boes, Eva, Danilo Fliser, Eberhard Ritz, et al.. (2005). Apolipoprotein A-IV Predicts Progression of Chronic Kidney Disease. Journal of the American Society of Nephrology. 17(2). 528–536. 68 indexed citations

18.

Kielstein, Jan T., Stefanie M. Bode‐Böger, H. J. Roth, et al.. (2004). Subpressor Dose Asymmetric Dimethylarginine Modulates Renal Function in Humans through Nitric Oxide Synthase Inhibition. Kidney & Blood Pressure Research. 27(3). 143–147. 54 indexed citations

19.

Kielstein, Jan T., et al.. (2003). Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. American Journal of Kidney Diseases. 42(1). 62–66. 109 indexed citations

20.

Rambausek, M., Danilo Fliser, & Eberhard Ritz. (1992). Albuminuria of hypertensive patients.. PubMed. 38 Suppl 1. S40–5. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact